Latest Drugs, Latest Approval in Thrombin inhibitors

What are Thrombin inhibitors?

Thrombin inhibitors are anticoagulants that bind to and inhibit the activity of thrombin therefore prevent blood clot formation. Thrombin inhibitors inactivate free thrombin and also the thrombin that is bound to fibrin.

Thrombin inhibitors are used to prevent arterial and venous thrombosis. They can also be used to prevent and treat deep vein thrombosis or used as prophylaxis in atrial fibrillation to avoid thromboembolism.

Name Updated
Bivalirudin (Bivalirudin [ bye-val-i-roo-din ]) 16-Aug-2023
Desirudin (Desirudin [ des-i-roo-din ]) 15-Aug-2023
Argatroban (Argatroban [ ar-gat-roe-ban ]) 13-Aug-2023
Angiomax (Bivalirudin [ bye-val-i-roo-din ]) 05-Aug-2023
Iprivask (Desirudin [ des-i-roo-din ]) 13-Jul-2023
Pradaxa (Dabigatran [ da-big-a-tran ]) 11-Jul-2023
Dabigatran (Dabigatran [ da-big-a-tran ]) 10-Jul-2023